(14 days)
For the quantitative determination of λ-GT in serum. For IN VITRO diagnostic use.
Gamma-Glutamyltransferase-SL Assay
I am sorry, but the provided text does not contain the information requested in your prompt regarding acceptance criteria and details about a study evaluating a device. The document is an FDA letter concerning the 510(k) premarket notification for a "y-Glutamyltransferase-SL Assay." It acknowledges the submission, states the device is substantially equivalent to a predicate device, and outlines regulatory responsibilities. It does not include performance data, study design details, or acceptance criteria for the assay.
§ 862.1360 Gamma-glutamyl transpeptidase and isoenzymes test system.
(a)
Identification. A gamma-glutamyl transpeptidase and isoenzymes test system is a device intended to measure the activity of the enzyme gamma-glutamyl transpeptidase (GGTP) in plasma and serum. Gamma-glutamyl transpeptidase and isoenzymes measurements are used in the diagnosis and treatment of liver diseases such as alcoholic cirrhosis and primary and secondary liver tumors.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.